查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1947901

全EXOME定序市场分析及预测（至2035年）：依类型、产品类型、服务、技术、应用、最终使用者、组件、功能及设备划分

Whole Exome Sequencing Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Application, End User, Component, Functionality, Device
出版日期: | 出版商: Global Insight Services | 英文 315 Pages | 商品交期: 3-5个工作天内

价格
简介目录

全EXOME定序市场预计将从2024年的144亿美元成长到2034年的903亿美元，复合年增长率约为32.4%。全EXOME定序市场涵盖对基因的整个蛋白质转录区（即EXOME）进行定序的技术和服务。该技术有助于识别与疾病相关的基因突变，并为个人化医疗提供重要资讯。测序技术的进步和成本的下降正在推动市场成长。基因组监测、罕见疾病诊断和精准肿瘤学研究的增加也推动了市场需求，凸显了数据分析和解读创新的必要性。

全EXOME序市场正经历强劲成长，主要得益于基因组研究和个人化医疗的进步。服务板块是市场成长的主要驱动力，其中诊断服务和临床研究应用是核心。这主要归功于全外显子定序在识别遗传疾病和製定治疗策略方面的重要作用。产品板块，尤其是试剂盒和试剂等耗材，紧随其后，反映了市场对可靠高效测序流程的持续需求。在服务板块中，临床诊断预计将继续保持领先地位，这主要得益于精准医疗需求的不断增长。研究应用，尤其是在肿瘤学领域，是表现第二好的板块，主要得益于对详细遗传资讯的需求。全EXOME定序在罕见疾病诊断中的日益普及进一步巩固了其市场潜力。技术进步，例如定序准确性的提高和成本的降低，预计将维持市场成长势头，并为相关人员带来盈利的机会。

市场区隔
类型 标靶EXOME定序、全EXOME显子定序
产品 试剂盒、试剂、设备和软体
服务 定序服务、数据分析服务、咨询服务
科技 合成定定序、离子半导体定序、奈米定序
应用领域 诊断、药物发现与开发、个人化医疗、农业与动物研究
最终用户 医院和诊所、研究机构、製药和生物技术公司、学术机构
成分 硬体、软体和服务
功能 资料管理、资料解读、资料存储
装置 桌上型音序器，可携式音序器

受基因组技术和个人化医疗发展的影响，全EXOME定序市场正经历市场份额的动态变化。定价策略竞争日益激烈，各公司力求在不牺牲品质的前提下提供高性价比的解决方案。为了满足日益增长的精准诊断需求，各公司不断创新，新产品层出不穷。该市场以强大的次世代定序平台开发平臺为特征，体现了对技术进步和提高可及性的不懈追求。全EXOME定序市场的竞争异常激烈，主要参与者透过策略联盟和收购争夺主导。监管政策影响显着，严格的指导方针塑造了市场准入和营运标准。北美地区凭藉着有利的法规结构和大量的研发投入，仍然是该市场的关键区域。同时，在政府主导的倡议和不断增长的医疗费用支出的推动下，亚太地区正崛起为一个充满潜力的市场。生物资讯学的进步和临床应用的拓展正在推动市场成长。

主要趋势和驱动因素：

全EXOME定序市场正经历强劲成长，这主要得益于技术进步和定序成本的下降。这一趋势使得更多研究机构和医疗服务提供者能够更便捷地使用这项技术。此外，遗传疾病的日益普遍以及对个人化医疗的需求，也推动了对更精准、更全面的基因分析的需求。另一个关键趋势是将人工智慧 (AI) 和机器学习技术应用于数据分析。这些技术能够增强对复杂基因数据的解读，并提供有助于开发更有效治疗方案的见解。此外，学术机构与产业界的合作正在促进创新，并加速新型定序解决方案的发展。对罕见疾病研究的日益关注也是一个驱动因素，因为全外EXOME定序为识别基因突变提供了强大的工具。随着医疗基础设施的改善和人们对先进基因检测兴趣的增长，发展中地区也涌现出新的机会。能够提供经济高效且扩充性解决方案的公司将占据有利地位，赢得市场份额。随着人们对基因检测益处的认识不断提高，预计该市场将继续扩张。

目录

第一章执行摘要

第二章 市集亮点

第三章 市场动态

  • 宏观经济分析
  • 市场趋势
  • 市场驱动因素
  • 市场机会
  • 市场限制
  • 复合年均成长率：成长分析
  • 影响分析
  • 新兴市场
  • 技术蓝图
  • 战略框架

第四章 细分市场分析

  • 市场规模及预测：依类型
    • 标靶EXOME定序
    • 全外EXOME定序
    • 其他的
  • 市场规模及预测：依产品划分
    • 成套工具
    • 试剂
    • 装置
    • 软体
    • 其他的
  • 市场规模及预测：依服务划分
    • 定序服务
    • 数据分析服务
    • 咨询服务
    • 其他的
  • 市场规模及预测：依技术划分
    • 合成定定序
    • 离子半导体定序
    • 奈米孔定序
    • 其他的
  • 市场规模及预测：依应用领域划分
    • 诊断
    • 药物发现与开发
    • 个人化医疗
    • 农业和畜牧业调查
    • 其他的
  • 市场规模及预测：依最终用户划分
    • 医院和诊所
    • 研究所
    • 製药和生物技术公司
    • 学术机构
    • 其他的
  • 市场规模及预测：依组件划分
    • 硬体
    • 软体
    • 服务
    • 其他的
  • 市场规模及预测：依功能划分
    • 资料管理
    • 数据解读
    • 资料储存
    • 其他的
  • 市场规模及预测：依设备划分
    • 桌上型音序器
    • 可携式音序器
    • 其他的

第五章 区域分析

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地区
  • 亚太地区
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳洲
    • 台湾
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 义大利
    • 其他欧洲地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 撒哈拉以南非洲
    • 其他中东和非洲地区

第六章 市场策略

  • 需求与供给差距分析
  • 贸易和物流限制
  • 价格、成本和利润率趋势
  • 市场渗透率
  • 消费者分析
  • 法规概述

第七章 竞争讯息

  • 市场定位
  • 市场占有率
  • 竞争基准
  • 主要企业的策略

第八章 公司简介

  • BGI Genomics
  • Novogene
  • Personalis
  • Gencove
  • Veritas Genetics
  • Macrogen
  • Roche Nimble Gen
  • Eurofins Genomics
  • Med Genome
  • Otogenetics
  • Admera Health
  • GATC Biotech
  • Sci Genom Labs
  • CD Genomics
  • Intellia Therapeutics
  • Genotypic Technology
  • Ce Ga T
  • Agilent Technologies
  • Centogene
  • Fulgent Genetics

第九章：关于我们

简介目录
Product Code: GIS10515

Whole Exome Sequencing Market is anticipated to expand from $14.4 billion in 2024 to $90.3 billion by 2034, growing at a CAGR of approximately 32.4%. The Whole Exome Sequencing Market encompasses the technology and services for sequencing all protein-coding regions of genes, known as exomes. This approach aids in identifying genetic variants associated with diseases, offering insights for personalized medicine. Advances in sequencing technology and decreasing costs are propelling market growth. The demand is driven by increasing research in genomics, rare disease diagnosis, and precision oncology, highlighting the need for innovation in data analysis and interpretation.

The Whole Exome Sequencing Market is experiencing robust growth, primarily driven by advancements in genomic research and personalized medicine. The services segment leads in performance, with diagnostic services and clinical research applications being pivotal. This is due to their role in identifying genetic disorders and informing treatment strategies. The products segment, particularly consumables such as kits and reagents, follows closely, reflecting the ongoing need for reliable and efficient sequencing processes. Within the services sub-segment, clinical diagnostics is anticipated to remain the top performer, fueled by increasing demand for precision medicine. Research applications, particularly in oncology, are the second highest performing sub-segment, driven by the need for detailed genetic insights. The rising adoption of whole exome sequencing in rare disease diagnosis further underscores its market potential. Technological advancements, such as improved sequencing accuracy and reduced costs, are expected to sustain market momentum, offering lucrative opportunities for industry stakeholders.

Market Segmentation
TypeTargeted Exome Sequencing, Whole Exome Sequencing
ProductKits, Reagents, Instruments, Software
ServicesSequencing Services, Data Analysis Services, Consultation Services
TechnologySequencing by Synthesis, Ion Semiconductor Sequencing, Nanopore Sequencing
ApplicationDiagnostics, Drug Discovery and Development, Personalized Medicine, Agriculture and Animal Research
End UserHospitals and Clinics, Research Institutes, Pharmaceutical and Biotechnology Companies, Academic Institutions
ComponentHardware, Software, Services
FunctionalityData Management, Data Interpretation, Data Storage
DeviceBenchtop Sequencers, Portable Sequencers

The Whole Exome Sequencing market is witnessing a dynamic shift in market share, driven by advancements in genomic technologies and personalized medicine. Pricing strategies are increasingly competitive, with companies striving to offer cost-effective solutions without compromising on quality. New product launches are frequent, as firms innovate to meet the growing demand for precision diagnostics. The market landscape is characterized by a robust pipeline of next-generation sequencing platforms, reflecting a commitment to technological evolution and enhanced accessibility. Competition in the Whole Exome Sequencing market is fierce, with key players vying for dominance through strategic partnerships and acquisitions. Regulatory influences are significant, with stringent guidelines shaping market entry and operational standards. North America remains a pivotal region, bolstered by favorable regulatory frameworks and substantial R&D investments. Meanwhile, Asia-Pacific is emerging as a lucrative market, driven by government initiatives and increasing healthcare expenditure. The market is poised for growth, with opportunities arising from advancements in bioinformatics and expanded clinical applications.

Geographical Overview:

The Whole Exome Sequencing (WES) market is witnessing substantial growth across diverse regions, each presenting unique opportunities. North America leads the market, driven by advanced healthcare infrastructure and significant research investments. The region's focus on precision medicine and genomics further bolsters market expansion. Europe follows, with strong governmental support for genomic research and personalized medicine initiatives. The region's robust regulatory framework enhances the adoption of WES technologies. In Asia Pacific, rapid advancements in healthcare infrastructure and increased healthcare expenditure are fueling market growth. Countries like China and India are emerging as key players, investing heavily in genomic research. Latin America and the Middle East & Africa are nascent markets with promising potential. In Latin America, growing awareness and investments in genomic medicine are key drivers. The Middle East & Africa are recognizing the importance of genomics in addressing regional health challenges, positioning themselves as future growth pockets in the WES market.

The Whole Exome Sequencing Market is navigating a complex landscape shaped by global tariffs, geopolitical tensions, and evolving supply chain dynamics. In Japan and South Korea, companies are mitigating tariff impacts by investing in local research and development, aiming to reduce reliance on imported sequencing technologies. China's strategic pivot towards self-sufficiency in biotech tools is accelerated by trade restrictions, fostering domestic innovation. Taiwan, while a key player in semiconductor supply, faces geopolitical vulnerabilities that may affect its biotech sector. Globally, the market is robust, driven by advancements in precision medicine. By 2035, growth will hinge on regional collaborations and resilient supply chains. Additionally, ongoing Middle East conflicts could disrupt energy prices, indirectly influencing production costs and logistics within the sequencing industry.

Key Trends and Drivers:

The Whole Exome Sequencing Market is experiencing robust growth, driven by technological advancements and decreasing sequencing costs. This trend is making the technology more accessible to a broader range of research institutions and healthcare providers. Additionally, the rising prevalence of genetic disorders and personalized medicine initiatives is fueling demand for more precise and comprehensive genetic analysis. Another significant trend is the integration of artificial intelligence and machine learning in data analysis. These technologies enhance the interpretation of complex genetic data, providing insights that can lead to more effective treatments. Furthermore, collaborations between academic institutions and industry players are fostering innovation and accelerating the development of novel sequencing solutions. The increasing focus on rare disease research is another driver, as whole exome sequencing offers a powerful tool for identifying genetic mutations. Opportunities are also emerging in developing regions, where healthcare infrastructure is improving, and there is growing interest in advanced genetic testing. Companies that can offer cost-effective and scalable solutions are well-positioned to capture market share. As awareness of the benefits of genetic testing grows, the market is set for sustained expansion.

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Application
  • 2.6 Key Market Highlights by End User
  • 2.7 Key Market Highlights by Component
  • 2.8 Key Market Highlights by Functionality
  • 2.9 Key Market Highlights by Device

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Targeted Exome Sequencing
    • 4.1.2 Whole Exome Sequencing
    • 4.1.3 Others
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Kits
    • 4.2.2 Reagents
    • 4.2.3 Instruments
    • 4.2.4 Software
    • 4.2.5 Others
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Sequencing Services
    • 4.3.2 Data Analysis Services
    • 4.3.3 Consultation Services
    • 4.3.4 Others
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Sequencing by Synthesis
    • 4.4.2 Ion Semiconductor Sequencing
    • 4.4.3 Nanopore Sequencing
    • 4.4.4 Others
  • 4.5 Market Size & Forecast by Application (2020-2035)
    • 4.5.1 Diagnostics
    • 4.5.2 Drug Discovery and Development
    • 4.5.3 Personalized Medicine
    • 4.5.4 Agriculture and Animal Research
    • 4.5.5 Others
  • 4.6 Market Size & Forecast by End User (2020-2035)
    • 4.6.1 Hospitals and Clinics
    • 4.6.2 Research Institutes
    • 4.6.3 Pharmaceutical and Biotechnology Companies
    • 4.6.4 Academic Institutions
    • 4.6.5 Others
  • 4.7 Market Size & Forecast by Component (2020-2035)
    • 4.7.1 Hardware
    • 4.7.2 Software
    • 4.7.3 Services
    • 4.7.4 Others
  • 4.8 Market Size & Forecast by Functionality (2020-2035)
    • 4.8.1 Data Management
    • 4.8.2 Data Interpretation
    • 4.8.3 Data Storage
    • 4.8.4 Others
  • 4.9 Market Size & Forecast by Device (2020-2035)
    • 4.9.1 Benchtop Sequencers
    • 4.9.2 Portable Sequencers
    • 4.9.3 Others

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Application
      • 5.2.1.6 End User
      • 5.2.1.7 Component
      • 5.2.1.8 Functionality
      • 5.2.1.9 Device
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Application
      • 5.2.2.6 End User
      • 5.2.2.7 Component
      • 5.2.2.8 Functionality
      • 5.2.2.9 Device
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Application
      • 5.2.3.6 End User
      • 5.2.3.7 Component
      • 5.2.3.8 Functionality
      • 5.2.3.9 Device
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Application
      • 5.3.1.6 End User
      • 5.3.1.7 Component
      • 5.3.1.8 Functionality
      • 5.3.1.9 Device
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Application
      • 5.3.2.6 End User
      • 5.3.2.7 Component
      • 5.3.2.8 Functionality
      • 5.3.2.9 Device
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Application
      • 5.3.3.6 End User
      • 5.3.3.7 Component
      • 5.3.3.8 Functionality
      • 5.3.3.9 Device
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Application
      • 5.4.1.6 End User
      • 5.4.1.7 Component
      • 5.4.1.8 Functionality
      • 5.4.1.9 Device
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Application
      • 5.4.2.6 End User
      • 5.4.2.7 Component
      • 5.4.2.8 Functionality
      • 5.4.2.9 Device
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Application
      • 5.4.3.6 End User
      • 5.4.3.7 Component
      • 5.4.3.8 Functionality
      • 5.4.3.9 Device
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Application
      • 5.4.4.6 End User
      • 5.4.4.7 Component
      • 5.4.4.8 Functionality
      • 5.4.4.9 Device
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Application
      • 5.4.5.6 End User
      • 5.4.5.7 Component
      • 5.4.5.8 Functionality
      • 5.4.5.9 Device
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Application
      • 5.4.6.6 End User
      • 5.4.6.7 Component
      • 5.4.6.8 Functionality
      • 5.4.6.9 Device
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Application
      • 5.4.7.6 End User
      • 5.4.7.7 Component
      • 5.4.7.8 Functionality
      • 5.4.7.9 Device
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Application
      • 5.5.1.6 End User
      • 5.5.1.7 Component
      • 5.5.1.8 Functionality
      • 5.5.1.9 Device
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Application
      • 5.5.2.6 End User
      • 5.5.2.7 Component
      • 5.5.2.8 Functionality
      • 5.5.2.9 Device
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Application
      • 5.5.3.6 End User
      • 5.5.3.7 Component
      • 5.5.3.8 Functionality
      • 5.5.3.9 Device
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Application
      • 5.5.4.6 End User
      • 5.5.4.7 Component
      • 5.5.4.8 Functionality
      • 5.5.4.9 Device
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Application
      • 5.5.5.6 End User
      • 5.5.5.7 Component
      • 5.5.5.8 Functionality
      • 5.5.5.9 Device
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Application
      • 5.5.6.6 End User
      • 5.5.6.7 Component
      • 5.5.6.8 Functionality
      • 5.5.6.9 Device
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Application
      • 5.6.1.6 End User
      • 5.6.1.7 Component
      • 5.6.1.8 Functionality
      • 5.6.1.9 Device
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Application
      • 5.6.2.6 End User
      • 5.6.2.7 Component
      • 5.6.2.8 Functionality
      • 5.6.2.9 Device
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Application
      • 5.6.3.6 End User
      • 5.6.3.7 Component
      • 5.6.3.8 Functionality
      • 5.6.3.9 Device
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Application
      • 5.6.4.6 End User
      • 5.6.4.7 Component
      • 5.6.4.8 Functionality
      • 5.6.4.9 Device
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Application
      • 5.6.5.6 End User
      • 5.6.5.7 Component
      • 5.6.5.8 Functionality
      • 5.6.5.9 Device

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 BGI Genomics
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Novogene
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Personalis
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Gencove
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Veritas Genetics
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Macrogen
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Roche Nimble Gen
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Eurofins Genomics
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Med Genome
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Otogenetics
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Admera Health
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 GATC Biotech
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Sci Genom Labs
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 CD Genomics
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Intellia Therapeutics
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Genotypic Technology
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Ce Ga T
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Agilent Technologies
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Centogene
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Fulgent Genetics
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us